alexa
Reach Us +1-217-403-9671
Prominence Of Pharmaceutical Quality System In The Product Life Cycle | 7468
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Prominence of pharmaceutical quality system in the product life cycle

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

Sunny kumar Mamidala, Harsha Pulipati and M. Vamshi Krishna

Posters: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.007

Abstract
Pharmaceutical Quality System is a new ICH tripartite guideline having reached its step4 of the ICH process and its under the quality guidelines considered as ICHQ10. It describes one comprehensive model for an effective Pharmaceutical Quality System that is based on International standard Organization (ISO) quality concepts, includes applicable GMP regulations & complements ICHQ8 pharmaceutical Development & ICH Q9 Quality risk management. It can be implemented throughout the different stages of a product lifecycle and is applicable to manufacturing sites. The aim of ICH Q10 is to enhance the quality and availability of medicines around the world in the interest of public health. The guideline applies to the system supporting the development and manufacturing of pharmaceutical drug substance and drug product, including biotechnological & biological products. Throughout Product Lifecycle i.e., Pharmaceutical Development, Technology Transfer, Commercial Manufacturing & Product Discontinuation. The topic of discussion includes the scope of the guideline and application. The elements of ICH Q10 should be applied in a manner that is appropriate and proportionate to each of the product lifecycle stages , recognizing the differences among the different goals of each stage.
Biography
Mr. Sunny Kumar has completed his B.Pharm in K.U.and presently pursuing their M.S. in Pharmaceutical Analysis and Quality Control from JNTUHYD. He is a member of IPGA.
Relevant Topics
Top